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Available online 19 March 2018Abnormalities in limbic neural circuits have been implicated in the onset of anxiety disorders. However, the mo-
lecular pathogenesis underlying anxiety disorders remains poorly elucidated. Here, we demonstrate that
myristoylated alanine-rich C-kinase substrate like 1 (MARCKSL1) regulates amygdala circuitry to control the ac-
tivity of the hypothalamic-pituitary-adrenal (HPA) axis, as well as induces anxiety-like behaviors in mice.
MARCKSL1 expressionwas predominantly localized in the prefrontal cortex (PFC), hypothalamus, hippocampus,
and amygdala of the adultmouse brain.MARCKSL1 transgenic (Tg)mice exhibited anxiety-like behaviors depen-
dent on corticotropin-releasing hormone. MARCKSL1 increased spine formation in the central amygdala, and
downregulation of MARCKSL1 in the amygdala normalized both increased HPA axis activity and elevated anxi-
ety-like behaviors in Tg mice. Furthermore, MARCKSL1 expression was increased in the PFC and amygdala in a
brain injury model associated with anxiety-like behaviors. Our findings suggest that MARCKSL1 expression in















Anxiety disorders have a reported lifetime prevalence of approxi-
mately 14–29% worldwide (Kessler et al., 2005). Patients with anxiety
disorders frequently present with comorbid psychiatric disorders,
such as major depressive disorder (Gorman, 1996–1997; Ressler and
Mayberg, 2007). Understanding the neuronal and molecular mecha-
nisms that trigger anxiety disorders is essential for developing effective
therapeutic strategies.
The limbic-cortical system is the principal neural circuit that is dys-
regulated and involved in the onset of psychiatric disorders, including
mood and anxiety disorders (Craske et al., 2009; Drevets, 2000;
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n open access article underprefrontal cortex (PFC), hippocampus, and amygdala are the main
brain areas dysregulated in these emotional disorders (Davidson,
2002; Drevets, 2000; Ressler and Nemeroff, 2000; Roozendaal et al.,
2009; Stein and Stein, 2008). In particular, the neural functioning of
the amygdala plays a pivotal role in the response to stress exposure
(Allen and Allen, 1974; Roozendaal et al., 2009), as well as in the
onset of anxiety disorders (Etkin et al., 2009; Lesscher et al., 2008;
Lyons and Thiele, 2010; Shekhar et al., 2005; Tye et al., 2011). However,
themolecular pathogenesis underlying anxiety disorders that evoke cir-
cuit dysregulation remains largely unknown.
Myristoylated alanine-rich C-kinase substrate like 1 (MARCKSL1) is
a member of the MARCKS family, a group of acidic proteins localized
to the plasma membrane. Microarray analysis suggested that
MARCKSL1 is expressed during development of the mouse PFC, and is
therefore a molecular candidate for neural development (Semeralul et
al., 2006). MARCKSL1 is known to be a primary substrate of protein
kinase C (PKC), and it regulates membrane-cytoskeletal plasticity by
altering the actin cytoskeleton (Arbuzova et al., 2002; Björkblom et al.,
2012; Sundaram et al., 2004). A previous study indicated that
MARCKSL1 regulates neuronal filopodia formation and bundle F-actin
(Björkblom et al., 2012). As postnatal neurodevelopmental processes
include various structural changes that mediate synaptic formation
and pruning, as well as dendritic and axonal growth (Webb et al.,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tion in structural maintenance and neuronal plasticity. However, the
precise physiological role of MARCKSL1 in the adult brain and its subse-
quent effects on behaviors remain largely unclear. AlthoughMARCKSL1
is predominantly expressed in the immature brain, it remains localized
in adult brain regions associated with emotional processing, including
the PFC, hippocampus, and amygdala (McNamara and Lenox, 1998).
Considering MARCKSL1 expression in the adult limbic system and its
putative role in altering neuronal plasticity and circuitry, we believed
that functional analysis of MARCKSL1 in vivo would facilitate our
understanding of the molecular mechanisms that control emotional
processes.
Here, using overexpression and knockdown techniques in vivo,
we analyzed the role of MARCKSL1 in brain function, focusing on
mood and anxiety. We demonstrate a clear association between
MARCKSL1 expression in neural circuitry and generation of anxiety-
like behaviors.
2. Materials and Methods
2.1. Generation of the Transgenic Mouse Model
The MARCKSL1 locus was amplified from the genome of an adult
(12-week-old) mouse brain via PCR with KOD FX Neo (TOYOBO).
A 0.6 kb fragment was identified that hybridized to themouseMarcksl1
cDNA. This fragmentwas isolatedwith 1.5% agarose gel electrophoresis,
and further purified with Wizard® SV Gel and PCR Clean-up System
(Promega Corporation). The fragment was subcloned into the XhoI
and EcoRI site of a pCAGGS vector (Addgene) by introducing Marcksl1
containing a HA tag (Fig. 2A). The amplified DNA plasmid was treated
with BamHI, ScaI, and SalI to prepare a 3.1 kb fragment, which was
microinjected into the pronucleus of fertilized B6D2F1 mouse eggs.
Male and female mice expressing the Marcksl1 transgene were
identified with Southern blotting. Heterozygous offspring were mated
to produce homozygous mutant animals. Genotypes at the pCAGGS-
Marcksl1 locus were determined with PCR.
For genotyping of mice, DNA was prepared from mouse tails. PCR
amplifications were performed through 35 cycles of denaturation
at 98 °C, annealing at 55 °C, and extension at 68 °C, followed by a
final extension at 68 °C. The following primers were used: 5′-
CTTCCTTTGTCCCAAATCTGTGCGGAGCCGAAATCT-3′ and 5′-GGGTT
AAGTCTCCATTGCTTCTCACGTGGCCATTCT-3′. PCR products were
electrophoresed in Tris-acetate-EDTA buffer containing 1% agarose
(Nippon Gene) and visualized by staining with ethidium bromide.
Procedures related to the generation of the transgenic (Tg) mice were
approved by the animal ethics committee of Kindai University.
2.2. Animals
The mice were bred and maintained in a specific pathogen-free
environment in the Institute of Experimental Animal Sciences,
Kindai University Medical School. Eight-week-old C57BL/6 N male
mice were purchased from Japan SLC. MARCKSL1 Tg C57BL/6N
mice were obtained by backcrossing MARCKSL1 Tg B6D2F1 to
C57BL/6N strain for at least five generations. Mice used in these
studies were propagated bymating+/Tg zygotes, thereby producing
+/+,+/Tg, and Tg/Tg offspring. The+/+mice were used aswild-type
(WT) controls. Three or four mice were each housed in a standard cage
on a 12 h light/dark cycle, with food and water available ad libitum.
Total numbers of male mice used in this study were as follows:
9–12-week-old WT (n = 71), +/Tg (n = 11), and Tg/Tg mice (n = 57).
The experiments were conducted in accordance with the guidelines
for the care and use of laboratory animals, and were approved by
the institutional committee of Kindai University and Kanazawa
Medical University.2.3. Drug Treatment
Antalarmin, a corticotropin-releasing hormone (CRH) receptor 1
(CRHR1) antagonist (Sigma-Aldrich, A8727), was dissolved in 4%
dimethylsulfoxide (DMSO) with 0.9% saline as a stock solution
(5 mg/ml). It was brought to a final concentration of 2 mg/ml with 4%
DMSO immediately before the experiment. Mice received intraperito-
neal injections of 4% DMSO control vehicle (WT, n = 7; Tg/Tg, n = 7)
or antalarmin (10 mg/kg; WT, n = 5; Tg/Tg, n = 5) 40 min before be-
havioral testing.
2.4. Small Interfering RNA (siRNA) Transfection In Vivo
For knockdown experiments, we used Marcksl1 siRNA (Sigma-
Aldrich) containing the following sequences: sense (5′-
CAUCAGCCAUUUGGUCUUATT-3′) and antisense (5′-UAAGACC
AAAUGGCUGAUGTT-3′). Marcksl1 siRNA (WT, n = 3; Tg/Tg, n = 9)
or scrambled siRNA (WT, n = 9; Tg/Tg, n = 7) was injected intracrani-
ally into the bilateral central amygdala (CeA) of mice following the pro-
cedures in a previous report (Lyons and Thiele, 2010), with i-Fect™
transfection reagents (Neuromics). Mice injected with the scrambled
siRNA were used as controls. Mice were anesthetized and placed in
a stereotaxic frame. The skull overlying the right and left primary
sensory cortex was carefully removed with a drill, and then Marcksl1
or scrambled siRNA with i-Fect reagent was injected at two sites
on each side within the CeA (coordinates from bregma: 1.2 mm
posterior/2.9 mm lateral, 1.7 mm posterior/2.9 mm lateral, all at
4.2 mm depth, 0.3 μl/site) with a glass capillary (tip diameter, 80 μm).
Mice were sacrificed 9–10 days after intracranial injections.
2.5. Brain Injury Models
The mice were placed in a stereotaxic frame (Narishige) after deep
anesthesia (Tanaka et al., 2013). The skull was exposed with a midline
skin incision, and skull bone overlying the left motor cortex was
removed. Hemicortical lesions (left side, depth: 1.0 mm in the motor
cortex) were induced in mice by using cortical ablation with a pipette
(n = 11) (Omoto et al., 2010; Tanaka et al., 2013). The injured area
consisted of primary and secondary motor areas of the cerebral cortex
(Tennant et al., 2011). Thereafter, the skull was replaced, the wound
was sutured, and the mice were housed in standard cages with free ac-
cess to food and water. Intact mice (n = 9) were used as controls.
2.6. Behavioral Tests
All behavioral tests were performed between 9 and 11 a.m. with
male mice (10–12-week-old). After each test, all testing apparatus
was cleaned with 0.5% hibitane (Sumitomo Dainippon Pharma) in
water to prevent potential bias based on olfactory cues.
2.6.1. Light/Dark Transition Test
The light/dark transition test was conducted with reference to
previous reports (Kim et al., 2013; Takao and Miyakawa, 2006).
The apparatus used for the light/dark transition test consisted of a
cage (30 cm × 30 cm × 30 cm) divided into two sections: a light
and a dark chamber. Mice were placed in the dark chamber and
allowed to move freely between the two chambers for 10 min. The
total number of transitions between chambers, the time spent in
the light chamber, and the latency to the first entrance into the
light chamber were recorded.
2.6.2. Elevated Plus Maze
The elevated plus maze was conducted with reference to previous re-
ports (Ihara et al., 2007; Komada et al., 2008). The elevated plus maze
consists of two open arms and two enclosed arms (30 cm × 6 cm) with
20 cm high walls. The arms and central square were made of gray plastic
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were arranged opposite each other. Mice were placed in the central
area of the apparatus (6 cm × 6 cm) facing the enclosed arms. The num-
ber of total entries, the percentage of open armentries, and the time spent
in the open arms were recorded for 10 min.
2.7. Statistical Analysis
All data are presented asmean± SEM. Statistical analyses were per-
formed with Statcel2 software. Differences between experimental
group pairs were analyzed with Student's t-tests. Differences among
the groups were analyzed by one-way ANOVA followed by the Tukey-
Kramer tests. P values b 0.05 were considered statistically significant.
Additional experimental procedures are available in the Supplemen-
tal Experimental Procedures.
3. Results
3.1. MARCKSL1 Expression in Emotion-Related Regions of the Adult Brain
First, we investigatedMARCKSL1 expression in the adult brain ofWT
mice, focusing on several regions associated with emotional processing,
including the PFC, hypothalamus, hippocampus, and amygdala. As
previously reported, we showed expression of MARCKSL1 in the
dentate gyrus of the hippocampus (McNamara and Lenox, 1998). In
addition, we found clear expression in the PFC, paraventricular
hypothalamic nucleus (PVN), and amygdala (Fig. 1A–D and Supple-
mentary Fig. 1A).
MARCKSL1 expression varied among amygdala subregions, with
abundant expression observed in the lateral amygdala (LA), but low ex-
pression observed in the CeA and basolateral amygdala (BLA) (Fig. 1D).
MARCKSL1 was mainly located in the dendrites and plasma membrane
of neurons, although some expression was observed in axons, illus-
trated by the pattern of expression in mossy fibers of the hippocampus
(Fig. 1A–D and Supplementary Fig. 1B).
We further examinedwhetherMARCKSL1was expressed in glial cells.
We observedMARCKSL1 expression in oligodendrocytes (Supplementary
Fig. 1C), but not in astrocytes (Supplementary Fig. 1D) or microglia
(Supplementary Fig. 1E). The pattern of expressionwithin neural circuitry
associated with emotion regulation suggests that MARCKSL1 expression
may be associated with emotional behavior in mice.
3.2. Generation of MARCKSL1 Tg Mice and Anxiety-Like Behavioral
Characterization
To elucidate the role ofMARCKSL1 in emotional behavior, we gener-
ated Tg mice that constitutively and ubiquitously overexpressed
MARCKSL1 with the CAG promoter (Fig. 2A). We obtained MARCKSL1
Tg mice lines using genotyping primers via the PCR method (Fig. 2A).
In the 12-week-old brain, MARCKSL1 Tg homozygous mice expressed
approximately five times more Marcksl1 mRNA compared with WT
mice (Supplementary Fig. 2A). ConsistentwithmRNA expression,west-
ern blotting for MARCKSL1 proteins in the brains of Tg/Tg mice showed
higher levels of expression compared with those of WT and +/Tg mice
(Supplementary Fig. 2B and C). In situ hybridization forMarcksl1mRNA
further demonstrated that Marcksl1 mRNA expression was induced in
all brain regions in adult Tg/Tg mice (Supplementary Fig. 2D and E). In
situ hybridization and immunohistochemical analysis confirmed this
observation, revealingmarked increases in the expression ofMARCKSL1
protein and mRNA in the BLA and CeA of Tg/Tg mice (Fig. 2B and C).
Gross appearance was comparable among the genotypes. There
were no significant differences in body weight or brain weight among
WT, +/Tg and Tg/Tg mice (Supplementary Fig. 2F and G). In addition,
compared with WT mice, both +/Tg and Tg/Tg mice showed no differ-
ence in brain morphology (Supplementary Fig. 2H).We next examined anxiety-related behavior in Tg/Tg mice. In the
light/dark transition test, Tg/Tg mice exhibited significantly longer la-
tencies to enter the light box, decreased numbers of transitions, and de-
creased time spent in the light box (Fig. 2D). In the elevated plus maze,
Tg/Tg mice showed significantly fewer total arm entries, a decreased
duration of time spent in the open arms and a lower percentage of
open arm entries (Fig. 2E). Moreover, compared with WT mice, Tg/Tg
mice spent less time in the center area of the open field in the open
field test (Supplementary Fig. 2I), and showed a trend towards a longer
time spent immobile in the forced swim test (Supplementary Fig. 2J). In
contrast, in the social behavioral test there was no difference between
WT and Tg/Tgmice (Supplementary Fig. 2K). Collectively, the results in-
dicate that MARCKSL1 Tg mice exhibited anxiety-like behaviors.
3.3. Anxiety-Like Behaviors in MARCKSL1 Tg Mice Depend on CRH
Production
We further tested the effects of activation of the hypothalamic-
pituitary-adrenal (HPA) axis under basal conditions in MARCKSL1
Tg mice. The HPA axis is the endocrine core of the stress system,
which involves hypothalamic CRH, pituitary corticotropin, and adrenal
corticosterone (de Kloet et al., 2005). CRH is produced in the PVN
(Smith and Vale, 2006), which is the primary driver of the HPA axis.
We therefore examined neural activity in CRH neurons in the PVN of
MARCKSL1 Tg mice by measuring c-Fos expression levels with immu-
nohistochemical analysis (Fig. 3A).
The number of CRH and c-Fos double-positive cells in the PVN was
significantly increased in MARCKSL1 Tg mice (Fig. 3B). Furthermore,
Crh mRNA levels in the hypothalamus (Fig. 3C) and plasma corticoste-
rone concentration (Fig. 3D) was significantly increased in Tg/Tg mice.
We further examined expression of Crh and stress-related receptor
mRNAs (Crhr1, Crhr2, Nr3c1, and Nr3c2) in the amygdala, hypothala-
mus, and hippocampus. Nr3c1 (also known as glucocorticoid receptor)
and Nr3c2 (also known as mineralocorticoid receptor) are receptors
for corticosterone and cortisol, and are widely distributed in the brain
(de Kloet et al., 2008; Morimoto et al., 1996; Reul and de Kloet, 1985).
There were no differences in the expression of these receptors between
WT and Tg/Tg mice (Supplementary Fig. 3A–C). These data suggest that
MARCKSL1 Tg mice have a dramatic over-activation of the HPA axis,
similar to that observed in mice exposed to chronic stress, which may
result in anxiety phenotypes.
We next investigated whether anxiety-like behavior in MARCKSL1
Tg mice depended on CRH levels. Tg/Tg mice were injected with
10 mg/kg antalarmin (CRHR1 antagonist; i.p.) or DMSO control vehicle
40 min prior to behavioral testing (Fig. 3E). Control Tg/Tg mice injected
with vehicle exhibited anxiety-like behaviors. However, antalarmin-
injected Tg/Tg mice showed near normalized behavior (similar to that
ofWTmice) in the light/dark transition test (Fig. 3F). These results indi-
cate that MARCKSL1 Tg mice show elevated anxiety-like behaviors in a
CRHR1 dependent manner.
3.4. Upregulation of MARCKSL1 Increases the Dendritic Spine Density of
Amygdala Spiny Neurons
Previous reports have indicated that projection neurons to the hypo-
thalamus originate predominantly in the amygdala and thus that this
area may be functionally important in the onset of anxiety disorders
(Kalin et al., 2004; LeDoux et al., 1988). To investigate the mechanisms
underlying CRH-dependent anxiety-like behaviors in MARCKSL1 Tg
mice, we examined dendritic spine density in amygdala neurons with
the Golgi-stain method. Dendritic spine densities were assessed in the
CeA, which mostly contains GABAergic spiny neurons (McDonald,
1982a; Sun and Cassell, 1993) (Fig. 4A), and the BLA and LA, which
are predominantly composed of excitatory neurons (Carlsen, 1988;
McDonald, 1982b, 1984) (Supplementary Fig. 4A and E). The neurons
Fig. 1.MARCKSL1 is expressed in adult brain regions associated with emotional processing. (A–D)MARCKSL1 (green) and NeuN (red) staining in the: (A) PFC (Cg, cingulate cortex; PrL,
prelimbic cortex); (B) hypothalamus (AH, anterior hypothalamic area; LH, lateral hypothalamic area; SCh, suprachiasmatic nucleus); (C) hippocampus (CA1, cornu ammonis 1; CA3, cornu
ammonis 3); and (D) amygdala. The pictures on the right are the magnified views of the squares in the left panels. Scale bars: A–D, (left) 200 μm, (right) 50 μm.
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by counting the number of spines at each 10 μm from the cell soma.
The spine density of spiny neurons of the CeA (Fig. 4B–D) and BLA
(Supplementary Fig. 4B–D) were significantly increased in Tg/Tg mice.
These data indicate that MARCKSL1 upregulation induced extensivespinogenesis of spiny neurons in the CeA and BLA. We further analyzed
the spines of Golgi-stained pyramidal neurons from the BLA and LA by
quantifying the number of spines per 10 μm of primary and secondary
branches (Supplementary Fig. 4E). Therewere no significant differences
in the spine density of BLA and LA pyramidal neurons betweenWT and
Fig. 2. Overexpression of MARCKSL1 induces anxiety-like behaviors. (A) Schema of the genomic organization ofMarcksl1 inserted into a pCAGGS vector. The arrows represent the positions of
genotyping primers. The dotted line box indicates the primer sequences. The right red bands are the result of genotyping. (B) In situ hybridization forMarcksl1mRNA (blue) in the amygdala
(three areas surrounded by the dotted lines) inWT and Tg/Tgmice. Scale bar, 200 μm. (C)MARCKSL1 (green) staining in the amygdala (three areas surrounded by the dotted lines) inWT and
Tg/Tg mice. Scale bar, 200 μm. (D and E) Light/dark transition test scores and elevated plus maze test scores in WT and Tg/Tg mice (each group, n = 11). Data are presented as
means ± SEM. *p b 0.05, **p b 0.01 (Student's t-test).
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MARCKSL1 may play a functional role in anxiety-like behaviors by con-
trolling dendritic spine formation in amygdala spiny neurons.
Wenext examinedneural activity in amygdala neurons bymeasuring
c-Fos expression under basal conditions in Tg/Tg mice (SupplementaryFig. 5A). The number of c-Fos-positive cells in the CeA was significantly
decreased in Tg/Tg mice (Supplementary Fig. 5B). In contrast, there
were no significant changes in c-Fos-positive cell numbers in either the
BLA or LA (Supplementary Fig. 5C and D). These results suggest that
the CeA circuitry is hypoactive in Tg/Tg mice.
Fig. 3.CRHantagonism reduces anxiety-like behavior inMARCKSL1 Tgmice. (A) Coronal brain sections showing immunohistochemical staining of CRH (green) and c-Fos (red) in the PVN. Scale
bar: left (lowmagnification), 100 μm; right (highmagnification), 50 μm. (B) The number of CRH and c-Fos double-positive cells in the PVN ofWT and Tg/Tgmice (each group, n= 4). Data are
presented as means ± SEM. *p b 0.05 (Student's t-test). (C) Expression of CrhmRNA in the hypothalamus was measured with real-time PCR (WT mice, n = 6; Tg/Tg mice, n = 7). Data are
presented as means ± SEM. **p b 0.01 (Student's t-test). (D) Blood plasma corticosterone concentration was quantified with ELISA (each group, n = 3). Data are presented as means ±
SEM. *p b 0.05 (Student's t-test). (E) Antalarmin (CRHR1 antagonist) or 4% DMSO (vehicle control) was infused into the peritoneal cavity 40–50 min prior to light/dark transition test.
(F) Light/dark transition test scores by antalarmin injection (WT control, n = 7; WT antalarmin, n = 5; Tg/Tg control, n = 7; Tg/Tg antalarmin, n = 5). Data are presented as means
± SEM. *p b 0.05 (one-way ANOVA followed by Tukey-Kramer test).
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Behaviors
To determine whether MARCKSL1 upregulation in the amygdala
was functionally involved in anxiety-like behaviors of Tg/Tg mice, we
used RNA interference to perform a knockdown of MARCKSL1 in the
CeA of Tg/Tg mice. We targeted CeA rather than BLA neurons, sincethe CeA contains the central inhibitory circuit of the amygdala, and
CeA output inhibitory neurons target the hypothalamus via the bed nu-
cleus of the stria terminalis (BNST) (Cassell et al., 1986; LeDoux et al.,
1988).
First, we determined the most effective Marcksl1 siRNA to knock-
down expression in vitro using western blotting (Supplementary Fig.
6A and B). The effect was verified in vivo using immunohistochemistry
Fig. 4. Spine numbers of CeA spiny neurons are increased inMARCKSL1 Tg mice. (A) Lowmagnification photomicrograph of representative Golgi-stained spiny neurons in the CeA. Scale
bar, 50 μm. (B) High magnification of representative Golgi-stained dendritic segments of spiny neurons in the CeA. Scale bar, 10 μm. Spines were counted, starting from the origin of a
branch and advancing in 10 μm steps. (C and D) Spine numbers per 10 μm length of dendrite from cell soma of spiny neuron in the CeA (WT mice, n = 3; Tg/Tg mice, n = 4). Data are
presented as means ± SEM. *p b 0.05 (Student's t-test).
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fused into the CeA of Tg/Tgmicewith i-Fect siRNA transfection reagents
for 5 days prior to behavioral testing (Fig. 5A and B). In vivo Marcksl1
siRNA transfection effectively decreased Marcksl1 mRNA expression in
the CeA for at least 10 days (Fig. 5C).
In the light/dark transition test, latency to enter the light box in
Marcksl1 siRNA-transfected Tg/Tg (Tg/Tg + Marcksl1 siRNA) mice re-
covered to the same level as scramble control siRNA-transfected WT
(WT + control siRNA) mice (Fig. 5D). The number of transitions and
the time spent in the light box by Tg/Tg + Marcksl1 siRNA mice recov-
ered to similar levels as those observed in WT + control siRNA mice
(Fig. 5D). In the elevated plus maze, Tg/Tg + Marcksl1 siRNA mice
tended to show a similar number of total arm entries, duration of time
spent in open arms, and number of entries into open arms, compared
with WT + control siRNA mice (Fig. 5E). These results demonstrate
that downregulation of MARCKSL1 in the CeA reduced anxiety-like be-
haviors in Tg/Tg mice.3.6. MARCKSL1 Downregulation in the CeA of MARCKSL1 Tg Mice Reduces
Activity of CRH Neurons in the PVN
The number of CRH and c-Fos double-positive cells in the PVN of
Tg/Tg+Marcksl1 siRNAmice was reduced comparedwith that in the
PVN of WT + control siRNA mice (Fig. 6A and B). Furthermore, Crh
mRNA levels (Fig. 6C) and corticosterone concentration (Fig. 6D) was
decreased in Tg/Tg + Marcksl1 siRNA mice. Hence, downregulation of
MARCKSL1 in the CeA of Tg/Tg mice reduced hyperactivity of CRH neu-
rons in the PVN and subsequently reduced corticosterone levels in the
blood plasma. To summarize, MARCKSL1 expression in the CeA appears
to play a critical role in anxiety-like behaviors.3.7. Brain Injury Increases MARCKSL1 Expression and Induces Anxiety-Like
Behaviors
Wepreviously investigated themolecularmechanism that mediates
neurological deficits and recovery of motor functions in a traumatic
brain injury model (Tanaka et al., 2013; Ueno et al., 2012). In this
study, we were subsequently interested in the neuronal mechanism
that may lead to altered emotional behaviors following injury. Indeed,
a previous report indicated that approximately 53% of patients with
traumatic brain injury experience major depressive disorder, and this
is associated with an increased risk of developing an anxiety disorder
(Bombardier et al., 2010).
We first examined whether anxiety-like behaviors were observed
following brain injury in our model. The injury was induced in the left
motor cortex (Supplementary Fig. 7A and B). In the light/dark transition
test, the injured mice showed a significantly increased latency to enter
the light box, and made fewer transitions between dark and light
boxes (Fig. 7A). In the elevated plusmaze test, micewith injury showed
fewer total entries into the maze arms, and remained for shorter
durations in the open arms (Fig. 7B). In our model, Crh mRNA levels in
the hypothalamus was significantly increased 14 days post injury
(Fig. 7C), and plasma corticosterone levels were also upregulated
(Fig. 7D).
To investigate the role of MARCKSL1 in this process, we examined
whether brain injury affectedMARCKSL1 expression in brain regions as-
sociated with emotional processing. Real-time PCR analysis revealed
thatMarcksl1 mRNA was increased in the PFC and amygdala following
injury, but not in the hypothalamus or hippocampus (Fig. 7E and
Supplementary Fig. 7C). Consistent with mRNA expression, we also
observed thatMARCKSL1 immunoreactivitywas increased in the amyg-
dala following brain injury, most markedly in the CeA (Fig. 7F). These
Fig. 5.KnockdownofMARCKSL1 ameliorates anxiety-like behavior inMARCKSL1 Tgmice. (A andB) For the in vivo experiment, siRNA (blue)was injected into theCeA (total 4 sites)with i-
Fect siRNA transfection reagents 5 days prior to behavioral tests. (C) In situ hybridization forMarcksl1mRNA (blue) in the amygdala after injection ofMarcksl1 siRNA into the CeA of Tg/Tg
mice. Scale bar, 200 μm. (D and E) Light/dark transition test and elevated plusmaze performance inMARCKSL1 knockdownmice (WT+ control siRNA, n= 7; Tg/Tg+ control siRNA, n=
7; Tg/Tg + Marcksl1 siRNA, n = 8). Data are presented as means ± SEM. *p b 0.05 (one-way ANOVA followed by Tukey-Kramer test).
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implies alteration of local circuitry, implicating the generation of emo-
tional behaviors.
4. Discussion
Our results demonstrate that MARCKSL1 upregulation in the CeA
promotes anxiety-like behaviors, both inMARCKSL1 Tg and brain injury
model mice. Here, the data suggest that MARCKSL1 plays a role in in-
creasing spine formation in the local amygdala circuit that affects the
output pathway to the hypothalamus, which increases the activity of
the HPA axis and results in the induction of anxiety-like behaviors.
Thus, we propose that regulation of MARCKSL1 in the amygdala plays
a pivotal role in anxiety disorders.
In concordance with anxiety-like behaviors, we found that
MARCKSL1 Tg mice showed signs of hyperactivity in the HPA axis. Themice exhibited CRH upregulation, CRH neuron activation in the PVN,
and consistent upregulation of plasma corticosterone levels. In addition,
CRHR1 suppression effectively attenuated anxiety-like behaviors.
Indeed, many previous studies have demonstrated that corticosterone
is the final product of the HPA axis that triggers stress responses
(Herman and Tasker, 2016; Matys et al., 2004; Vale et al., 1981).
Furthermore, the HPA axis response is dysregulated via continuous
hyperactivity of CRH neurons in the PVN of patients with major depres-
sive and anxiety disorders (de Kloet et al., 2005; Dedic et al., 2012).
Altogether, our data suggest that anxiety-like behaviors in MARCKSL1
Tg mice are evoked by hyperactivation of the HPA axis via a
CRHR1-dependent mechanism.
We next observed two abnormalities in amygdala neurons of
MARCKSL1 Tg mice. First, spiny neurons in the CeA and BLA of Tg mice
showed significantly increased numbers of dendritic spines. Second, c-
Fos-positive, active neurons in the CeA were significantly decreased in
Fig. 6. MARCKSL1 inhibition in the CeA reduces the activity of CRH neurons in the PVN. (A) Immunohistochemical staining of CRH and c-Fos in the PVN of control or Marcksl1 siRNA-
injected mice. Scale bar, 50 μm. (B) The number of CRH and c-Fos double-positive cells in the PVN of control orMarcksl1 siRNA-injected WT and Tg/Tg mice (each group, n = 4). Data
are presented as means ± SEM. *p b 0.05, **p b 0.01 (one-way ANOVA followed by Tukey-Kramer test). (C) Relative expression of Crh mRNA in the hypothalamus examined with
real-time PCR (each group, n = 3). *p b 0.05 (one-way ANOVA followed by Tukey-Kramer test). (D) Corticosterone concentration in the blood, quantified with ELISA (WT + control
siRNA, n = 3; Tg/Tg + control siRNA, n = 3; Tg/Tg + Marcksl1 siRNA, n = 4). *p b 0.05, **p b 0.01 (one-way ANOVA followed by Tukey-Kramer test).
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pothalamus via the BNST (Cassell et al., 1986; LeDoux et al., 1988). Be-
cause elevated expression of MARCKSL1 affected the spines in and
activity of the CeA, and subsequently led to HPA axis activation, anxi-
ety-like behaviors in Tg mice might be evoked through dysregulated
amygdala output via the hypothalamic pathway. Indeed, our RNA inter-
fering experiments support this neuronal mechanism. Specific knock-
down of MARCKSL1 expression in the CeA suppressed the activity ofCRH neurons in the PVN and rescued anxiety-like behaviors in
MARCKSL1 Tg mice. Thus, MARCKSL1 in CeAmay be one of the key mol-
ecules that regulate activity of CRH neurons in the PVN and thus controls
states of anxiety.
The precisemechanism bywhichMARCKSL1 controls spine numbers
is still unclear. It is well known that the actin cytoskeleton is essential for
the formation and stabilization of filopodia, which is an immature den-
dritic spine, and for spine morphology. PKC and Jun N-terminal protein
Fig. 7. Brain injury induces anxiety-like behaviors and MARCKSL1 expression in the amygdala. (A and B) Light/dark transition test and elevated plus maze performance inWTmice after
brain injury (controlmice, n=6; injurymice, n=8). Data are presented asmeans±SEM. *p b 0.05, **p b 0.01 (Student's t-test). (C) Relative expression ofCrhmRNA in thehypothalamus
of mice with brain injury examined with real-time PCR (control mice, n = 6; injury mice, n = 8). Data are presented as means ± SEM. **p b 0.01 (Student's t-test). (D) Corticosterone
concentration in blood plasma was quantified with ELISA (control mice, n = 5; injury mice, n = 7). Data are presented as means ± SEM. *p b 0.05 (Student's t-test). (E) Relative
expression ofMarcksl1 mRNA in the amygdala of mice with brain injury, examined with real-time PCR (control mice, n = 4; injury mice, n = 8). Data are presented as means ± SEM.
*p b 0.05 (Student's t-test). (F) MARCKSL1 (green) staining in the amygdala of control and 14-days post-injury mice. Scale bar, 200 μm.
71T. Tanaka et al. / EBioMedicine 30 (2018) 62–73kinase (JNK) are known to regulate actin stability through phosphoryla-
tion of MARCKSL1 (Arbuzova et al., 2002; Björkblom et al., 2012;
Sundaram et al., 2004). Neurons expressing MARCKSL1 or MARCKSL1
phosphorylated by JNK promote neuronal dynamics such as increasing
filopodia numbers along the dendrites by bundling F-actin (Björkblomet al., 2012). In this view, MARCKSL1 would be an important intrinsic
factor that regulates dendritic spine formation. Interestingly, previous
studies have indicated that JNK1 regulates dendritic architecture and
synaptic plasticity in neurons (Chang et al., 2003; Coffey, 2014;
Komulainen et al., 2014), and that inhibition or knockout of JNK1 induces
72 T. Tanaka et al. / EBioMedicine 30 (2018) 62–73an anxiolytic effect in mice (Mohammad et al., 2018; Reinecke et al.,
2013). Given that JNK1 is a dominant regulator of MARCKSL1 actin bun-
dling, it is highly relevant that JNK1 knockout mice show a low anxiety
phenotype andMARCKSL1 overexpression increased anxiety. Further in-
vestigation is required to understand the mechanism by which
MARCKSL1 overexpression increases the dendritic spines of spiny neu-
rons. We also do not know whether MARCKSL1 controls dendritic
spine formation in other neuronal subtypes and brain regions. It is possi-
ble that MARCKSL1-mediated structural changes in other neuronal sys-
tems control brain function.
In conclusion, our study demonstrates the potential involvement of
MARCKSL1 in the regulation of anxiety-like behaviors inmousemodels.
Although MARCKSL1 overexpression induced clear anxiety-like behav-
iors, the neuronal mechanisms underlying how the increased spines in
amygdala spiny neurons decrease activity in the CeA and subsequently
activate the HPA axis remain unclear. In addition, the physiological roles
of MARCKSL1 on anxiety behaviors in various living situations have not
been investigated in this study. Hence, it will be important to conduct
further multidirectional analyses to understand the underlying mecha-
nisms and neural substrates of anxiety. These analyses will require the
use of multiple experimental models, such as stress-exposure and
brain injury models, in both inbred mice strains and genetically
engineered mice, ranging from early developmental stages to adult-
hood. Elucidating the functional roles of MARCKSL1 in the CeA and
BLA should be one of the primary goals of future research.
Original data of this study are available atMendeley Data (http://dx.
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